PMEF
CELU icon

Point72 Middle East FZE’s Celularity CELU Stock Holding History

Point72 Middle East FZE’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-459
Closed -$2.44K – 1498
2023
Q2 		$2.44K Buy
+459
New +$2.94K ﹤0.01% 1459
2023
Q1 		– Sell
-600
Closed -$7.74K – 1705
2022
Q4 		$7.74K Buy
+600
New +$11.1K ﹤0.01% 1752

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Middle East FZE's CELU Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Celularity (CELU) in Q3 2023, closing a stake of 459 shares — an estimated $2.44K sold.

Point72 Middle East FZE first reported a position in CELU in Q4 2022 and held it in 2 quarters. The position peaked at $7.74K in Q4 2022. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 459 Celularity shares in Q3 2023, an estimated $2.44K.
  • Point72 Middle East FZE first reported a position in Celularity in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Celularity position peaked at $7.74K in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.